MSTN and endothelial dysfunction: As myostatin amplified endothelial dysfunction induced by the uremic toxin indoxyl sulfate, we conducted a retrospective observational study in 186 hemodialysis patients to examine the association between myostatin serum concentrations and all-cause mortality, as well as cardiovascular and AV access complications—conditions in which endothelial dysfunction plays a key role.